Tevogen Bio Holdings (TVGN) Amortization of Deferred Charges (2023 - 2025)
Tevogen Bio Holdings (TVGN) reported Amortization of Deferred Charges of $24577.0 for Q1 2025, down 84.57% on a YoY basis from $159305.0 in Q1 2024, and up 55.51% quarter-over-quarter from $15804.0 in Q4 2024.
Tevogen Bio Holdings (TVGN) Amortization of Deferred Charges (2023 - 2025) Analysis & Trends
Tevogen Bio Holdings has reported Amortization of Deferred Charges for 3 years, with the latest figure at $24577.0 in Q1 2025.
- For the quarter ending Q1 2025, Amortization of Deferred Charges fell 84.57% year-over-year to $24577.0; the trailing twelve-month figure through Mar 2025 stood at $52847.0 (down 95.09% YoY), and the FY2024 full-year result was $187575.0, down 84.46% from the prior year.
- Amortization of Deferred Charges for Q1 2025 stood at $24577.0, up from $15804.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $317562.0 in Q4 2023, with the low at $12466.0 in Q3 2024.
- Historically, Amortization of Deferred Charges has averaged $177356.1 across 3 years, with a median of $224220.0 in 2023.
- The largest YoY upside for Amortization of Deferred Charges was 44.9% in 2024 against a maximum downside of 95.84% in 2024.
- Tevogen Bio Holdings' Amortization of Deferred Charges stood at $317562.0 in 2023, then slumped by 95.02% to $15804.0 in 2024, then surged by 55.51% to $24577.0 in 2025.
- The last three Amortization of Deferred Charges figures came in at $24577.0 (Q1 2025), $15804.0 (Q4 2024), and $12466.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Tevogen Bio Holdings | 173.69 Mn | 173.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 24,577.00 |
| Mar 31, 2025 | 24,577.00 |
| Dec 31, 2024 | 15,804.00 |
| Dec 31, 2024 | 15,804.00 |
| Sep 30, 2024 | 12,466.00 |
| Sep 30, 2024 | 12,466.00 |
| Mar 31, 2024 | 159,305.00 |
| Mar 31, 2024 | 159,305.00 |
| Dec 31, 2023 | 317,562.00 |
| Dec 31, 2023 | 317,562.00 |
| Sep 30, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Mar 31, 2023 | 289,135.00 |
| Mar 31, 2023 | 289,135.00 |